May 19, 2020, Vol 323, No. 19, Pages 1873-1982
Finding Effective Treatments for COVID-19Scientific Integrity and Public Confidence in a Time of Crisis
Jesse L. Goodman, MD, MPH; Luciana Borio, MD
free access has active quiz
JAMA. 2020;323(19):1899-1900. doi:10.1001/jama.2020.6434
This Viewpoint discusses the risks to patients and public health posed by the FDA’s politically pressured Emergency Use Authorization (EUA) of chloroquine and hydroxychloroquine for COVID-19 treatment, and proposes principles to follow to ensure new therapies are studied properly and quickly to maximize benefits and minimize risks to patients.